Literature DB >> 10638425

The role of the pedunculopontine region in basal-ganglia mechanisms of akinesia.

L E Munro-Davies1, J Winter, T Z Aziz, J F Stein.   

Abstract

The akinesia of Parkinsonism is relieved by pallidotomy and subthalamic nucleotomy, but not by thalamotomy. Therefore, this disabling symptom probably depends upon connections other than the pallidalthalamocortical tracts, possibly efferents of the medial pallidum descending to the upper brainstem. We have previously demonstrated akinesia in the normal monkey following radiofrequency lesioning in the region of the pedunculopontine nucleus (PPN), one of the primary targets for descending pallidal outflow. Here, we confirm that selectively destroying neurones in the PPN area, whilst sparing fibres of passage, results in an akinetic state in normal macaques.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10638425     DOI: 10.1007/s002210050921

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  24 in total

Review 1.  Role of the pedunculopontine nucleus in controlling gait and sleep in normal and parkinsonian monkeys.

Authors:  C Karachi; Chantal Francois
Journal:  J Neural Transm (Vienna)       Date:  2017-01-13       Impact factor: 3.575

Review 2.  Restoration of locomotive function in Parkinson's disease by spinal cord stimulation: mechanistic approach.

Authors:  Romulo Fuentes; Per Petersson; Miguel A L Nicolelis
Journal:  Eur J Neurosci       Date:  2010-10       Impact factor: 3.386

Review 3.  The pedunculopontine tegmental nucleus and experimental parkinsonism. A review.

Authors:  Masaru Matsumura
Journal:  J Neurol       Date:  2005-10       Impact factor: 4.849

4.  Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease.

Authors:  Carine Karachi; David Grabli; Frédéric A Bernard; Dominique Tandé; Nicolas Wattiez; Hayat Belaid; Eric Bardinet; Annick Prigent; Hans-Peter Nothacker; Stéphane Hunot; Andreas Hartmann; Stéphane Lehéricy; Etienne C Hirsch; Chantal François
Journal:  J Clin Invest       Date:  2010-07-12       Impact factor: 14.808

5.  Glutamate and GABA modulate dopamine in the pedunculopontine tegmental nucleus.

Authors:  Björn Steiniger; Beate D Kretschmer
Journal:  Exp Brain Res       Date:  2003-02-26       Impact factor: 1.972

Review 6.  Pedunculopontine stimulation from primate to patient.

Authors:  Erlick A C Pereira; Dipankar Nandi; Ned Jenkinson; John F Stein; Alexander L Green; Tipu Z Aziz
Journal:  J Neural Transm (Vienna)       Date:  2011-03-30       Impact factor: 3.575

7.  Changes in the neuronal activity in the pedunculopontine nucleus in chronic MPTP-treated primates: an in situ hybridization study of cytochrome oxidase subunit I, choline acetyl transferase and substance P mRNA expression.

Authors:  M Gomez-Gallego; E Fernandez-Villalba; A Fernandez-Barreiro; M T Herrero
Journal:  J Neural Transm (Vienna)       Date:  2006-09-21       Impact factor: 3.575

Review 8.  Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.

Authors:  Gunasingh J Masilamoni; Yoland Smith
Journal:  J Neural Transm (Vienna)       Date:  2017-08-31       Impact factor: 3.575

9.  Gait disorders in parkinsonian monkeys with pedunculopontine nucleus lesions: a tale of two systems.

Authors:  David Grabli; Carine Karachi; Emmanuelle Folgoas; Morgane Monfort; Dominique Tande; Stewart Clark; Olivier Civelli; Etienne C Hirsch; Chantal François
Journal:  J Neurosci       Date:  2013-07-17       Impact factor: 6.167

10.  Altered neuronal activity relationships between the pedunculopontine nucleus and motor cortex in a rodent model of Parkinson's disease.

Authors:  Bhooma R Aravamuthan; Debra A Bergstrom; Robin A French; Joseph J Taylor; Louise C Parr-Brownlie; Judith R Walters
Journal:  Exp Neurol       Date:  2008-06-09       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.